Agilent Technologies

A · NYSE · Health Care · Financials, fiscal 2016 to 2025

A · Last close · October 26, 2026

$175.96

Agilent Technologies' revenue rose 6.7% to $6.9 billion in fiscal 2025. Its operating margin was 21.3%, down from 22.9% a year earlier. Free cash flow was $1.2 billion, down 16.1%. It paid out $707 million in dividends and buybacks, 61% of free cash flow. The diluted share count fell 2.1%.

AGILENT TECHNOLOGIES, INC. Latest fiscal year ended October 31, 2025 10-K filed December 22, 2025 · 0001090872-25-000087 Updated October 9, 2026

Revenue

$6.9B

6.7%

Operating margin

21.3%

1.6 pts

Net income

$1.3B

1.1%

Free cash flow

$1.2B

16.1%

Return on capital

16.5%

0.4 pts

Market cap

$49.8B

Oct 26 close

P/E

34.7x

On $5.07 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

About these figures. Agilent's filings from fiscal 2023 tag a negative figure as its equity including minority owners' share, so its shareholders' equity is used throughout (Agilent has almost no minority owners).

Charts show fiscal years, from the 10-K filings.

Revenue and margins

Revenue

US$ billions, fiscal years

Margins

Percent of revenue

GrossOperatingNetFree cash flow

Net income and earnings per share

From fiscal 2016 to 2025, earnings per share grew 14.0% a year and net income 12.2% a year, as buybacks cut the share count by 13%.

Net income

US$ billions, fiscal years; loss years in red.

Diluted earnings per share

US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity

Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.

Return on capitalReturn on equity

Cash flow

Free cash flow

US$ billions. Cash from operations minus capital expenditure; negative years in red.

Payouts and share count

Dividends and buybacks

US$ billions, cash paid in each fiscal year

DividendsShare buybacks

Diluted share count

Weighted-average diluted shares, millions

Valuation

Two ways to value Agilent Technologies yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.

What Agilent Technologies says to expect

Fourth quarter 2026: revenue and EPSFourth-quarter 2026 revenue is expected in the range of $1.98 billion to $2.0 billion, growth of 6.4% to 7.4% reported and up 5.2% to 6.2% core (1)(5) . Non-GAAP EPS (4) is expected in the range of $1.71 to $1.74 per share.
Fiscal year 2026: revenueFiscal year 2026 revenue is now expected in the range of $7.49 billion to $7.51 billion, representing a range of up 7.8% to 8.1% reported and up 5.8% to 6.0% core, (1)(5) an increase of 65 basis points at the midpoint.

The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed August 26, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Discounted cash flow (DCF)

A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Agilent Technologies' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.

Value per share on three example scenarios, from Agilent Technologies' fiscal 2025 free cash flow of $1.2B, net cash of −$1.6B at October 31, 2025 and 285 million diluted shares, from its filings. The scenarios are fitted to Agilent Technologies: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 0.5% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 10%: 9% for a business of moderate risk (Life Sciences Tools & Services), plus 1 point for unsteady results (revenue fell in two of the last five years); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

From the filings

Starting free cash flow, US$ millions

Cash from operations minus capital spending in fiscal 2025.

Net cash, US$ millions

Cash and short-term investments minus debt and finance leases at October 31, 2025. Negative means net debt.

Diluted shares, millions

Weighted-average diluted shares in fiscal 2025.

Your assumptions

Start from

Fitted to Agilent Technologies's own revenue growth, as above. Cautious: growth of -1.5% then 0% a year, 2% after year 10, a 11% discount rate. Base: growth of 0.5% then 1.5% a year, 2.5% after year 10, a 10% discount rate. Optimistic: growth of 2.5% then 3% a year, 3% after year 10, a 9% discount rate.

Free cash flow growth, years 1 to 5 (% a year)

Free cash flow growth, years 6 to 10 (% a year)

Growth after year 10 (% a year)Long-run growth forever after year 10. Usually close to inflation, and always below the discount rate.

Discount rate (% a year)The yearly return an investor wants for the risk. A higher rate gives a lower value.

Value per share on these assumptions

—

Last close, October 26, 2026: $175.96
Value on these assumptions, against the last close: —

Cash flows in years 1 to 10, valued today: —
Everything after year 10, valued today: —
Plus net cash: —
Share of value from after year 10: —

Projected free cash flow

US$ billions. Each column is one year's projected free cash flow, split into what it is worth today and the part removed by discounting.

Value todayRemoved by discounting

How the value changes with two assumptions

Value per share in US$, with the growth rates above. The highlighted cell matches the current assumptions.

How the model works. Free cash flow grows at the first rate for five years and the second rate for five more, and each year is discounted at the discount rate. Everything after year 10 is valued as year-10 cash flow × (1 + growth after year 10) ÷ (discount rate − growth after year 10), discounted back ten years. Net cash is added and the total is divided by diluted shares. The result depends entirely on the assumptions. It is not a forecast, a price target or a recommendation. The last close is the consolidated US closing price, from Databento.

Price-to-earnings (P/E) method

Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.

Value per share on three example scenarios, from Agilent Technologies' earnings per share of $5.07 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 34.7×, the middle of Agilent Technologies' own P/E today, its peers' median and its sector's median (Agilent Technologies' own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 11%, 10% and 9%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

Earnings per share, US$

Diluted earnings per share over the four quarters to July 31, 2026, from the 10-Qs and 10-K.

P/E multiple

P/E today is the last close divided by the latest earnings per share, the four quarters' where available. Peers: Illumina, Mettler Toledo.

Earnings growth in the years ahead (% a year) Starts at Agilent Technologies' revenue growth over the last 3 years, 0.5% a year, as the base scenario does.

Earnings per share in the years ahead, US$

Year 1Year 2Year 3Year 4Year 5

Type your own estimate for any year; the years after it carry on at the growth rate.

Apply the multiple to earnings

A multiple on a future year's earnings gives the price then, brought back to today at the discount rate below.

Discount rate (% a year) The yearly return an investor wants for the risk, as in the cash flow model.

Value per share today at this multiple

—

Last close, October 26, 2026: $175.96
Value at this multiple, against the last close: —
Agilent Technologies' P/E at the last close: 34.7×

Company	Last close	Earnings per share	P/E today
IlluminaILMN	$271.04	$5.36	50.6×
Mettler ToledoMTD	$1,669.62	$44.38	37.6×
Agilent TechnologiesA	$175.96	$5.07	34.7×

How the P/E method works. Value per share is earnings per share times the multiple. On a future year's earnings, that gives the price in that year, which is brought back to today at the discount rate: price ÷ (1 + discount rate) for each year ahead. It is quick and easy to compare across companies, but it ignores debt and cash, and earnings can swing with one-off gains and charges, so a multiple says most about steady, profitable businesses. Like the cash flow model, the result depends entirely on the assumptions you choose. It is not a forecast, a price target or a recommendation.

Balance sheet

Fiscal year end	FY21	FY22	FY23	FY24	FY25
Cash and short-term investments	1,484	1,053	1,590	1,329	1,789
Debt incl. finance leases	2,729	2,769	2,735	3,390	3,354
Net debt (negative means net cash)	1,245	1,716	1,145	2,061	1,565
Net debt to EBITDA	0.8x	0.9x	0.7x	1.2x	0.9x
Debt to equity	0.5x	0.5x	0.5x	0.6x	0.5x
Interest coverage	16.6x	19.3x	14.2x	15.5x	13.2x
Current ratio	2.2x	2.0x	2.6x	2.1x	2.0x
Quick ratio	1.7x	1.5x	2.0x	1.6x	1.5x

US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Insider trades

Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Agilent Technologies shares on the open market, and 3 insiders sold $3.2 million, $2.0 million of it under trading plans set up in advance.

Date	Insider	Trade	Shares	Price	Value	Filing
Sep 4, 2026	Mikael DolstenDirector	Sold	634	$151.38	$95,975	Form 4
May 29, 2026	Mikael DolstenDirector	Sold	1,600	$135.42	$216,672	Form 4
Dec 1, 2025	Mikael DolstenDirector	Sold	2,600	$149.81	$389,506	Form 4
Nov 26, 2025	Rodney GonsalvesV.p., Corporate Controller	Sold	3,000	$154.99	$464,970	Form 4
Nov 18, 2025	Padraig McDonnellPresident and CEO, Director	Sold plan	911	$143.24	$130,492	Form 4
Nov 12, 2025	Padraig McDonnellPresident and CEO, Director	Sold plan	12,490	$150.00	$1.9 million	Form 4

Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Piotroski F-score

The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.

Test	FY23	FY24	FY25
Net income is positive	Pass	Pass	Pass
Cash from operations is positive	Pass	Pass	Pass
Return on assets rose	Pass	Pass	Fail
Cash from operations exceeds net income	Pass	Pass	Pass
Debt fell relative to assets	Pass	Fail	Pass
Current ratio rose	Pass	Fail	Fail
Share count didn't rise	Pass	Pass	Pass
Gross margin rose	Fail	Pass	Fail
Revenue rose relative to assets	Pass	Fail	Fail
F-score	8 of 9	6 of 9	5 of 9
Accruals ratio	−5.0%	−4.1%	−2.1%

The accruals ratio is net income minus cash from operations, over average total assets.

Compare

Put Agilent Technologies side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

Company	Year	Revenue growth	Operating margin	Free cash flow margin	Return on capital	Net debt to EBITDA	F-score	Compare
Agilent Technologies	FY25	6.7%	21.3%	16.6%	16.5%	0.9x	5
Avantor	FY25	−3.4%	−3.8%	7.5%	−2.0%	22.0x	5	Compare
Illumina	FY25	−0.7%	18.6%	21.4%	20.3%	0.3x	8	Compare
Mettler Toledo	FY25	4.0%	—	21.1%	50.5%	1.7x	7	Compare
Charles River Laboratories	FY25	−0.8%	0.6%	12.9%	0.4%	4.5x	4	Compare

Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score above.

10 years of figures

Fiscal year	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Income statement
Revenue	4,202	4,472	4,914	5,163	5,339	6,319	6,848	6,833	6,510	6,948
Revenue growth	4.1%	6.4%	9.9%	5.1%	3.4%	18.4%	8.4%	−0.2%	−4.7%	6.7%
Gross profit	2,197	2,409	2,680	2,805	2,837	3,407	3,722	3,465	3,535	3,643
Research and development	329	341	387	404	495	441	467	481	479	455
Operating income	615	807	904	941	846	1,347	1,618	1,350	1,488	1,479
Net income	462	684	316	1,071	719	1,210	1,254	1,240	1,289	1,303
Diluted EPS (US$)	1.40	2.10	0.97	3.37	2.30	3.94	4.18	4.19	4.43	4.57
Diluted shares (millions)	329	326	325	318	312	307	300	296	291	285
Cash flow
Cash from operations	793	889	1,087	1,021	921	1,485	1,312	1,772	1,751	1,559
Capital expenditure	139	176	177	155	119	188	291	298	378	407
Free cash flow	654	713	910	866	802	1,297	1,021	1,474	1,373	1,152
Dividends paid	150	170	191	206	222	236	250	265	274	282
Share buybacks	434	194	422	723	469	788	1,139	575	1,150	425
Acquisitions	261	128	516	1,408	0	547	52	51	862	4
Stock-based compensation	58	60	70	72	83	110	125	111	129	128
Balance sheet at fiscal year end
Cash and short-term investments	2,289	2,678	2,247	1,382	1,441	1,484	1,053	1,590	1,329	1,789
Debt incl. finance leases	1,904	2,011	1,799	2,407	2,359	2,729	2,769	2,735	3,390	3,354
Total assets	7,794	8,426	8,541	9,452	9,627	10,705	10,532	10,763	11,846	12,727
Total liabilities	3,548	3,591	3,970	4,704	4,754	5,316	5,227	4,918	5,948	5,986
Shareholders' equity	4,243	4,831	4,567	4,748	4,873	5,389	5,305	5,845	5,898	6,741
Margins and ratios
Gross margin	52.3%	53.9%	54.5%	54.3%	53.1%	53.9%	54.4%	50.7%	54.3%	52.4%
Operating margin	14.6%	18.1%	18.4%	18.2%	15.8%	21.3%	23.6%	19.8%	22.9%	21.3%
Net margin	11.0%	15.3%	6.4%	20.7%	13.5%	19.1%	18.3%	18.1%	19.8%	18.8%
Free cash flow margin	15.6%	15.9%	18.5%	16.8%	15.0%	20.5%	14.9%	21.6%	21.1%	16.6%
Return on capital	14.5%	17.7%	10.9%	19.0%	12.5%	19.3%	19.8%	17.9%	16.9%	16.5%
Return on equity	11.0%	15.1%	6.7%	23.0%	14.9%	23.6%	23.4%	22.2%	21.9%	20.6%
Return on assets	6.0%	8.4%	3.7%	11.9%	7.5%	11.9%	11.8%	11.7%	11.4%	10.6%
Net debt to EBITDA	−0.5x	−0.7x	−0.4x	0.9x	0.8x	0.8x	0.9x	0.7x	1.2x	0.9x

US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)

Source: Agilent Technologies' Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Agilent Technologies.